Designer DNA drug could be used to delay paralysis in ALS


In virtually all persons with amyotrophic lateral sclerosis (ALS) and in up to half of all cases of Alzheimer’s disease (AD) and frontotemporal dementia, a protein called TDP-43 is lost from its normal location in the nucleus of the cell.

Study demonstrates effectiveness of a procedure done under the skin to treat uncontrolled hypertension

Previous article

Klara, a transparent fish for research on aging

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News